Late Stage Investors & VC Firms in Atlanta

12 firms in this list, with a median first check of $4M. 1 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
DR Drive Capital APMKASAS41 people · Leads rounds	88🔒	Columbus	US	Pre-Seed–Late Stage	$5M – $30M	+ Add to CRM
BI BIP Ventures CJMBMFDD19 people · Follows rounds	88🔒	Atlanta	US	Pre-Seed–Late Stage	—	+ Add to CRM
NO Noro-Moseley Partners AMATSMVK10 people	88🔒	Atlanta	US	Series A–Late Stage	$5M – $20M	+ Add to CRM
UN University Growth Fund ABABAGBP37 people · Follows rounds	88🔒	Atlanta	US	Series A–Late Stage	—	+ Add to CRM
KI Kinetic Ventures, L.L.C. DRJTWTNC13 people	88🔒	Atlanta	US	Seed–Late Stage	$1M – $5M	+ Add to CRM
IN Invesco ATDJLASC22 people	88🔒	Atlanta	US	Late Stage	—	+ Add to CRM
SO Socium Ventures ADDYNCTH4 people	88🔒	Atlanta	US	Seed–Late Stage	$3M – $25M	+ Add to CRM
BR Brace Pharma DERSTB3 people	88🔒	Atlanta	US	Late Stage	—	+ Add to CRM
IM Imlay Investments RDAF2 people	88🔒	Atlanta	US	Seed–Late Stage	—	+ Add to CRM
DU Duart Mull	88🔒	Atlanta	US	Growth–Late Stage	$250M	+ Add to CRM
BI BIP Capital PIAPCHDD5 people	88🔒	Atlanta	US	Seed–Late Stage	—	+ Add to CRM
BR BrightEdge	88🔒	Atlanta	US	Seed–Late Stage	—	+ Add to CRM

Drive Capital

ColumbusPre-Seed–Late Stage$5M – $30M

APMKASAS41 people

BIP Ventures

AtlantaPre-Seed–Late Stage

CJMBMFDD19 people

Noro-Moseley Partners

AtlantaSeries A–Late Stage$5M – $20M

AMATSMVK10 people

University Growth Fund

AtlantaSeries A–Late Stage

ABABAGBP37 people

Kinetic Ventures, L.L.C.

AtlantaSeed–Late Stage$1M – $5M

DRJTWTNC13 people

Invesco

AtlantaLate Stage

ATDJLASC22 people

Socium Ventures

AtlantaSeed–Late Stage$3M – $25M

ADDYNCTH4 people

Brace Pharma

AtlantaLate Stage

DERSTB3 people

Imlay Investments

AtlantaSeed–Late Stage

RDAF2 people

Duart Mull

AtlantaGrowth–Late Stage$250M

BIP Capital

AtlantaSeed–Late Stage

PIAPCHDD5 people

BrightEdge

AtlantaSeed–Late Stage

Data sourced from public filings and firms' own websites — see our methodology.